搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
crvs
/
财务摘要
Corvus Pharmaceuticals Inc
CRVS
添加自选
11.865
USD
-0.675
-5.38%
交易中 09/24, 15:15(美东)
997.73M
总市值
亏损
市盈率 TTM
Corvus Pharmaceuticals Inc
11.865
-0.675
-5.38%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
CRVS 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Corvus Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
997.73M
股息TTM
0.00
市盈率 TTM
-21.33
每股收益TTM
-0.56
营业收入
--
净利润
-62.29M
净资产收益率
-30.46%
总资产收益率
-28.26%
Corvus Pharmaceuticals Inc 财报日历
最新发布
8月 6, 2026
每股收益 / 预测值
-0.19
/-0.16
营业收入 / 预测值
--
/0.00
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-89.06%
-0.19
-172.23%
-0.15
12.91%
-0.15
79.66%
-0.12
-44.07%
-0.10
281.18%
0.21
-30.56%
-0.18
-392.12%
-0.60
47.86%
-0.07
31.25%
-0.12
35.67%
-0.14
--
-0.12
--
-0.14
--
-0.17
--
-0.21
--
-0.68
--
--
--
--
--
--
--
--
净利润
-124.54%
-17.96M
-190.12%
-13.69M
-1.72%
-12.32M
74.74%
-10.16M
-87.66%
-8.00M
366.50%
15.19M
-82.07%
-12.11M
-570.28%
-40.22M
34.46%
-4.26M
27.59%
-5.70M
32.22%
-6.65M
59.54%
-6.00M
22.24%
-6.50M
5.11%
-7.87M
-6.28%
-9.82M
-38.96%
-14.83M
28.84%
-8.36M
28.35%
-8.30M
-133.77%
-9.24M
-8.95%
-10.67M
资产负债率
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.00%
--
--
--
--
--
0.00%
--
0.00%
--
0.00%
--
--
--
--
--
--
--
--
利润表
营业利润
-88.08%
-19.30M
-49.94%
-14.88M
-50.73%
-12.22M
-45.72%
-10.57M
-72.87%
-10.26M
-58.68%
-9.92M
-43.43%
-8.11M
-30.49%
-7.25M
-5.57%
-5.94M
4.88%
-6.25M
0.26%
-5.65M
55.42%
-5.56M
19.83%
-5.62M
11.32%
-6.57M
16.80%
-5.67M
-37.87%
-12.47M
37.88%
-7.01M
35.44%
-7.41M
31.07%
-6.81M
8.11%
-9.05M
净利润
-124.54%
-17.96M
-190.12%
-13.69M
-1.72%
-12.32M
74.74%
-10.16M
-87.66%
-8.00M
366.50%
15.19M
-82.07%
-12.11M
-570.28%
-40.22M
34.46%
-4.26M
27.59%
-5.70M
32.22%
-6.65M
59.54%
-6.00M
22.24%
-6.50M
5.11%
-7.87M
-6.28%
-9.82M
-38.96%
-14.83M
28.84%
-8.36M
28.35%
-8.30M
-133.77%
-9.24M
-8.95%
-10.67M
资产负债表
流动资产
191.59%
220.97M
427.46%
239.95M
7.00%
58.21M
55.97%
66.94M
57.03%
75.78M
99.08%
45.49M
94.62%
54.41M
29.69%
42.92M
27.30%
48.26M
-35.72%
22.85M
-35.97%
27.96M
-35.45%
33.09M
-35.62%
37.91M
-44.77%
35.55M
-38.77%
43.66M
-34.90%
51.27M
-14.81%
58.88M
-6.46%
64.37M
57.30%
71.31M
49.99%
78.76M
流动负债总额
60.75%
13.67M
30.51%
12.11M
-73.50%
9.38M
-82.60%
8.07M
-36.22%
8.51M
38.08%
9.28M
415.39%
35.40M
535.79%
46.41M
69.70%
13.34M
-18.94%
6.72M
-36.11%
6.87M
-47.78%
7.30M
-22.63%
7.86M
-10.52%
8.29M
10.94%
10.75M
23.64%
13.98M
-17.83%
10.16M
-33.42%
9.27M
-20.22%
9.69M
-5.80%
11.30M
总资产
167.46%
239.27M
325.98%
253.19M
3.21%
71.12M
36.83%
80.47M
38.57%
89.46M
48.28%
59.44M
51.27%
68.91M
13.23%
58.81M
11.23%
64.56M
-31.12%
40.08M
-33.25%
45.55M
-35.35%
51.94M
-37.28%
58.04M
-42.54%
58.20M
-37.65%
68.24M
-32.66%
80.35M
-15.41%
92.54M
-7.27%
101.29M
27.97%
109.45M
113.60%
119.32M
总负债
51.05%
13.95M
23.76%
12.52M
-72.72%
9.91M
-81.24%
8.71M
-30.76%
9.23M
50.49%
10.11M
429.03%
36.34M
506.38%
46.41M
55.82%
13.34M
-27.97%
6.72M
-43.35%
6.87M
-51.15%
7.65M
-29.59%
8.56M
-19.35%
9.33M
-1.37%
12.13M
10.53%
15.67M
-6.44%
12.15M
-22.11%
11.57M
-8.13%
12.29M
4.91%
14.18M
总权益
180.86%
225.33M
387.95%
240.68M
87.93%
61.20M
478.35%
71.77M
56.62%
80.23M
47.84%
49.33M
-15.81%
32.57M
-71.98%
12.41M
3.52%
51.23M
-31.72%
33.36M
-31.06%
38.68M
-31.53%
44.29M
-38.44%
49.48M
-45.54%
48.87M
-42.25%
56.12M
-38.49%
64.68M
-16.61%
80.39M
-4.94%
89.72M
34.67%
97.16M
148.28%
105.15M
现金流量表
经营净额
-166.54%
-15.40M
-25.55%
-10.37M
-8.58%
-9.19M
-51.34%
-9.57M
-5.40%
-5.78M
-60.23%
-8.26M
-63.83%
-8.46M
-16.32%
-6.32M
-4.94%
-5.48M
36.42%
-5.16M
31.54%
-5.17M
21.58%
-5.43M
14.70%
-5.22M
-26.26%
-8.11M
-10.08%
-7.55M
17.76%
-6.93M
51.59%
-6.12M
26.89%
-6.42M
16.46%
-6.86M
-8.96%
-8.43M
投资净额
70.62%
-5.96M
-3513.76%
-144.85M
278.86%
10.88M
32.70%
-2.62M
-15.98%
-20.30M
60714.29%
4.24M
-162.42%
-6.08M
-122.17%
-3.89M
-308.11%
-17.50M
-100.15%
-7.00K
40.29%
-2.32M
477.17%
17.55M
-236.59%
-4.29M
117.99%
4.60M
-94.20%
-3.88M
-12.42%
3.04M
-79.40%
3.14M
-627.73%
-25.57M
-531.75%
-2.00M
-65.08%
3.47M
融资净额
-99.54%
166.00K
68267.74%
190.75M
-99.89%
20.00K
620.00%
360.00K
17.78%
35.77M
--
279.00K
--
18.61M
-85.07%
50.00K
304.07%
30.37M
-100.00%
0.00
--
0.00
--
335.00K
--
7.52M
--
4.00K
-100.00%
0.00
-100.00%
0.00
--
--
--
--
-98.53%
18.00K
28546.88%
18.33M
常见问题
Corvus Pharmaceuticals Inc的流动资产是多少?
根据Corvus Pharmaceuticals Inc的FY2025财报,流动资产为58.21M(同比变化7.00)。
Corvus Pharmaceuticals Inc的总资产是多少?
根据Corvus Pharmaceuticals Inc的FY2025财报,Corvus Pharmaceuticals Inc的总资产为71.12M(同比变化3.21)。
Corvus Pharmaceuticals Inc的总负债是多少?
根据Corvus Pharmaceuticals Inc的FY2025财报,Corvus Pharmaceuticals Inc的总负债为9.91M(同比变化-72.72)。
Corvus Pharmaceuticals Inc的总权益是多少?
根据Corvus Pharmaceuticals Inc的FY2025财报,Corvus Pharmaceuticals Inc的总权益为61.20M(同比变化87.93)。
Corvus Pharmaceuticals Inc的净营业收入是多少?
根据Corvus Pharmaceuticals Inc的FY2025财报,Corvus Pharmaceuticals Inc的净营业收入为-42.97M(同比变化-55.99)。
Corvus Pharmaceuticals Inc的净投资是多少?
根据Corvus Pharmaceuticals Inc的FY2025财报,Corvus Pharmaceuticals Inc的净投资为-7.80M(同比变化71.63)。
Corvus Pharmaceuticals Inc的净融资是多少?
根据Corvus Pharmaceuticals Inc的FY2025财报,Corvus Pharmaceuticals Inc的净融资为36.43M(同比变化-25.70)。
Corvus Pharmaceuticals Inc的每股收益(EPS)是多少?
根据Corvus Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为-0.19(同比变化81.05)。
Corvus Pharmaceuticals Inc的净利润是多少?
根据Corvus Pharmaceuticals Inc的FY2025财报,净利润为-15.28M(同比变化75.47)。
Corvus Pharmaceuticals Inc的股东权益回报率(ROE)是多少?
根据Corvus Pharmaceuticals Inc的FY2025财报,股东权益回报率(ROE)为-32.60(同比变化81.36)。
Corvus Pharmaceuticals Inc的资产回报率(ROA)是多少?
根据Corvus Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为-21.83(同比变化79.95)。
Corvus Pharmaceuticals Inc的营业利润是多少?
根据Corvus Pharmaceuticals Inc的FY2025财报,营业利润为-42.97M(同比变化-55.99)。